SMAD3 and pulmonary arterial hypertension: The contribution of the TGF-ß signaling pathway to the development of PAH is well-known as increased activity is a classic finding among these patients, enhancing smooth muscle cells and endothelial cells proliferation through SMAD3 and SMAD2 activation [59].